The U.S. Food and Drug Administration (FDA) approved the first drug, Oxervate (cenegermin), for the treatment of neurotrophic keratitis, a rare diseas...
Press Release

FDA permits marketing of transcranial magnetic stimulation for obsessive compulsive disorder
The U.S. Food and Drug Administration (FDA) permitted the marketing of the Brainsway Deep Transcranial Magnetic Stimulation System for the treatment o...

Mylan launches first generic for Adcirca tablets
HERTFORDSHIRE, England, and PITTSBURGH: Global pharmaceutical company Mylan N.V. announced the U.S. launch of Tadalafil Tablets USP, 20 mg, the first ...

FDA approves first generic version of EpiPen
The U.S. Food and Drug Administration approved the first generic version of EpiPen and EpiPen Jr (epinephrine) auto-injector for the emergency treatme...

FDA approves new vaginal ring for one year of birth control
The U.S. Food and Drug Administration (FDA) approved Annovera (segesterone acetate and ethinyl estradiol vaginal system), which is a combined hormonal...

FDA approves first generic drug under new pathway
The U.S. Food and Drug Administration (FDA) approved several strengths of the potassium chloride oral solution as the first generic drugs to receive a...

FDA approves Galafold for a rare genetic disorder, Fabry disease
New Delhi: The U.S. Food and Drug Administration (FDA) approved Galafold (migalastat), the first oral medication for the treatment of adults with Fabr...

FDA approves Poteligeo injection for two rare types of non-Hodgkin lymphoma
The U.S. Food and Drug Administration (FDA) approved Poteligeo (mogamulizumab-kpkc) injection for intravenous use for the treatment of adult patients ...

Sanofi launches multiple sclerosis drug in India
Aubagio® offers patients diagnosed with Multiple Sclerosis the efficacy and convenience of once-a-day oral treatment Over 200,000 people in India are ...

Constellation Alpha Capital acquires diagnostic chain Medall for Rs 1450 crore
NEW YORK and CHENNAI, India: Constellation Alpha Capital Corp, a special purpose acquisition company focused on consolidating the healthcare services ...